Best Radiation Oncologist Doctors at BLK-Max Super Speciality Hospital Delhi

Dr. S Hukku is a highly experienced radiation oncologist currently serving as the Director at BLK-Max Super Speciality Hospital in New Delhi, India. With over 43 years of dedicated practice, Dr. Hukku has built a reputation for excellence in patient care and innovative treatment approaches. His commitment to utilizing the latest advancements in oncology ensures that each patient receives personalized and effective care tailored to their unique needs. Dr. Hukku's extensive expertise and compassionate approach have made him a trusted name in the field of oncology.

• Specializes in advanced radiation therapy techniques for cancer treatment.
• Recognized for his contributions to the field of oncology and patient care over a distinguished 43-year career.
• Believes in a patient-centered care philosophy, emphasizing communication and support throughout the treatment journey.
• Engaged in international collaborations to enhance treatment methodologies and share best practices in oncology.
• Contributed to the advancement of cancer treatment through participation in various research initiatives and clinical trials.

Dr. Shikha Halder is a highly respected radiation oncologist with over 31 years of dedicated experience in the field. Currently serving as the Director at BLK-Max Super Speciality Hospital in New Delhi, India, she is committed to providing innovative and compassionate care for her patients. Dr. Halder employs a patient-centered approach, utilizing the latest advancements in oncology to tailor treatment plans that meet the unique needs of each individual, ensuring the highest standard of care throughout their journey.

• Specializes in radiation oncology, focusing on personalized treatment strategies for cancer patients.
• Recognized for her contributions to improving patient outcomes through advanced therapeutic techniques.
• Believes in a holistic approach to patient care, emphasizing emotional support and comprehensive treatment.
• Has collaborated with leading international institutions to enhance cancer treatment methodologies.
• Actively engages in research and clinical trials, contributing to advancements in cancer treatment protocols.